EROSION III: OCT- vs Angio-based Reperfusion Strategy for STEMI
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bin Liu
Second Hospital of Jilin University
Principal Investigator - Bo Yu
The Second Affiliated Hospital of Harbin Medical University
Study Chair - Chunmei Wang
Beijing Anzhen Hospital
Principal Investigator - Dajun Yuan
The Second Affilated Hospital of Dalian Medical University
Principal Investigator - Jianping Li
Peking University First Hospital
Principal Investigator - Lang Li
First Affiliated Hospital of Guangxi Medical University
Principal Investigator - Ling Li
The First Affiliated Hospital of Zhengzhou University
Principal Investigator - Xinshun Gu
The Second Hospital of Hebei Medical University
Principal Investigator - Yanqing Wu
Second Affiliated Hospital of Nanchang University
Principal Investigator - Yin Liu
Tianjin Chest Hospital
Principal Investigator - Yining Yang
First Affiliated Hospital of Xinjiang Medical University
Principal Investigator - Zhiqi Sun
Daqing Oil Field Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Beijing Anzhen Hospital
Beijing, Beijing Municipality, China
- Peking University First Hospital
Beijing, Beijing Municipality, China
- the First Affiliated Hospital of Guangxi Medical University
Nanning, Guangxi, China
- the Second Hospital of Hebei Medical University
Shijiazhuang, Hebei, China
- Daqing Oil Field Hospital
Daqing, Heilongjiang, China
- the 2nd Affiliated Hospital of Harbin Medical University
Harbin, Heilongjiang, China
- the First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China
- the Second Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China
- the Second Hospital of Jilin University
Jilin City, Jilin, China
- the Second Affiliated Hospital of Dalian Medical University
Dalian, Liaoning, China
- Tianjin Chest Hospital
Tianjin, Tianjin Municipality, China
- First Affiliated Hospital of Xinjiang Medical University
Ürümqi, Xinjiang, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 21 Dec 2017
- Primary completion
- 2 Jan 2020
- Completion
- 24 Dec 2020
- Last update posted
- 19 Aug 2021
- Registered enrollment
- 246
- Registry id
- NCT03571269
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.